Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer
- 1 September 1993
- journal article
- Published by Elsevier in The Breast
- Vol. 2 (3) , 134-137
- https://doi.org/10.1016/0960-9776(93)90055-k
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breastThe Journal of Pathology, 1992
- Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)Nature, 1991
- Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosisNature, 1990
- bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferationCell, 1989
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal TranslocationNew England Journal of Medicine, 1988
- Improved immunohistochemical localization of tissue antigens using modified methacarn fixation.Journal of Histochemistry & Cytochemistry, 1985
- Methacarn (methanol-Carnoy) fixationHistochemistry and Cell Biology, 1970
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957